Ying Xuan Chua, Ph.D.

Multi-PI

Houston Methodist

Dr. Corrine Ying Xuan Chua is a Research Assistant Professor in the Department of Nanomedicine at the Houston Methodist Research Institute and an Assistant Professor of Nanomedicine Research in Medicine at Weill Cornell Medical College. She earned her B.S. in Microbiology magna cum laude from the University of Louisiana at Lafayette, followed by an M.S. in Cellular and Structural Biology from the University of Texas Health Science Center at San Antonio, where she investigated mechanisms of therapeutic resistance in alveolar rhabdomyosarcoma using genetically engineered murine cancer models. She received her Ph.D. in Cancer Biology summa cum laude from the University of Texas MD Anderson Cancer Center, where she explored oncogenic pathways and identified therapeutically actionable targets for glioma. Her doctoral work resulted in publications in leading peer-reviewed journals, including Oncogene, PNAS, and The Journal of Pathology, and earned multiple distinctions such as the Caroline Ross Endowed Fellowship Award and the Professor Alexander Wang Memorial Scholarship Award. Dr. Chua joined the Grattoni Laboratory in 2016 as a postdoctoral fellow, focusing on nanotechnology-enabled drug delivery platforms for cancer, HIV, and other therapeutic areas. Her current research is centered on developing nanofluidic systems for precision oncology, with an emphasis on intratumoral delivery of immunotherapies to enhance efficacy while reducing systemic toxicity. She also leads efforts to engineer implantable platforms capable of sustained antigen-specific immune activation toward the development of therapeutic cancer vaccines.